The Role of TXNIP in Skeletal Muscle Physiology and Related Diseases: Current Perspectives
Journal of Inflammation Research · 2026-10 · Volume 19 · 1-17
DOI: 10.2147/jir.s637774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-10. Verfasst von Jiazhe Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Thioredoxin-interacting protein (TXNIP) is a multifunctional regulatory protein of the α-arrestin family that acts as a redox sensor, an energy-responsive molecule, and a transcription-associated regulator. TXNIP has emerged as a key regulator of skeletal muscle homeostasis and has been implicated in the pathogenesis of multiple muscle disorders. Skeletal muscle is a principal site of systemic glucose disposal, accounting for more than 70% of insulin-stimulated glucose uptake in the human body. TXNIP has been implicated in sarcopenia, obesity-related insulin resistance, limb ischemia-induced muscle injury, disuse muscle atrophy, and hereditary muscular dystrophy through multiple mechanisms, including glutathione metabolic regulation, ferroptosis, NLRP3 inflammasome activation, impaired GLUT4 membrane translocation, and altered mitochondrial substrate oxidation. Recent advances in gene editing, single-cell sequencing, metabolomics, and human clinical research have enabled a more detailed characterization of TXNIP-related molecular mechanisms in skeletal muscle. This review provides a systematic synthesis of recent evidence on TXNIP in skeletal muscle, organized around seven themes: its molecular characteristics, expression and regulatory patterns in skeletal muscle, physiological functions, disease-specific pathogenic mechanisms, intervention-related regulatory networks, current limitations, and future perspectives. This review aims to provide a mechanistic rationale for targeting TXNIP as a potential strategy for the prevention and treatment of skeletal muscle-related diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
- Shaoxing Yuecheng People's Hospital, Shaoxing, Zhejiang, People's Republic of China.
- Frontier Innovation Center, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.
- Department of Physiology, College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
ORCID-Profile: Ludan Zhang
Zitieren
APA
Du, J., Gao, X., Yao, S., & Zhang, L. (2026). The Role of TXNIP in Skeletal Muscle Physiology and Related Diseases: Current Perspectives. Journal of Inflammation Research, Volume 19, 1-17. https://doi.org/10.2147/jir.s637774
Vancouver
Du J, Gao X, Yao S, Zhang L. The Role of TXNIP in Skeletal Muscle Physiology and Related Diseases: Current Perspectives. Journal of Inflammation Research. 2026;Volume 19:1-17. doi:10.2147/jir.s637774
BibTeX
@article{Du2026,
author = {Du, Jiazhe and Gao, Xudong and Yao, Sai and Zhang, Ludan},
title = {The Role of TXNIP in Skeletal Muscle Physiology and Related Diseases: Current Perspectives},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--17},
doi = {10.2147/jir.s637774}
}
EUVIMED